Summary: CathWorks FFRangio™ u
Need: The FAME trial demonstrated the clinical and economic value of using FFR to provide objective, multi-vessel data for PCI decision-making. However, conventional FFR requires additional intervention and adds procedure costs, risks, and time that reduces its practicality as an ‘every patient’ solution. CathWorks FFRangio™ makes every case, intra-procedural FFR a clinically and economically efficient for PCI decision-making.
Value: CathWorks delivers objective, intra-procedural, precise FFR measurements to optimize PCI decision making, for every patient. This measurement and analysis are performed without additional interventions using the angiograms already performed during the procedure. It allows for the conformance to the ACC appropriate use guidelines, and utilizes the FFR research from the New England Journal of Medicine of FAME and FAME 2 trials which demonstrated the improvement in decision making and outcomes utilizing FFR to decide and guide PCI decisions.